Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Anticancer efficacy of dry and fresh Allium ascalonicum (shallot) against HepG2 cell line

Vetriselvi Pandurangan, Safreen Shaikh Dawood Amanulla, Kumaresan Ramanathan.




Abstract

Background: Liver cancer is a deadly disease and devastating public health problem globally. Natural plant products with potent growth inhibition, and apoptosis induction properties are extensively being investigated for their cancer-preventive potential. Allium ascalonicum, being an important part of the diet across various countries, possesses numerous therapeutic effects and health-enhancing properties such as cancer prevention.

Aims and Objective: To investigate anticancer activity of dry and fresh A. ascalonicum.

Materials and Methods: The organic (ethanol) extracts of dry and fresh shallot bulb (A. ascalonicum) were prepared and tested for in vitro anticancer efficacy on liver cancer cell line HepG2 by MTT (3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay.

Results: The results showed that both dry and fresh shallot extracts have anticancer potential with inhibitory concentration (IC50) of 50 µg/mL.

Conclusion: The plant investigated possesses remarkable anticancer activity. Further studies are essential for the isolation of lead molecules from the plant to treat liver cancer.

Key words: Allium ascalonicum; HepG2 Cell Line; MTT Assay; Anticancer Activity






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.